STOCK TITAN

Stryker Corp SEC Filings

SYK NYSE

Welcome to our dedicated page for Stryker SEC filings (Ticker: SYK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Stryker Corporation filings document the regulatory record of a New York Stock Exchange-listed medical technology issuer with operations in MedSurg, Neurotechnology and Orthopaedics. Its 8-K reports cover operating results, financial-condition updates, material events, Regulation FD disclosures and exhibits tied to company press releases.

The filing record also describes governance and capital-structure matters, including definitive proxy materials, annual-meeting votes, director elections, auditor ratification, executive-compensation votes, common stock and listed senior unsecured notes. Recent material-event filings include cybersecurity incident disclosures and amendments describing operational and reporting updates connected to Stryker's information technology environment.

Rhea-AI Summary

Montagnino Kimberly Ann reported acquisition or exercise transactions in this Form 4 filing.

Stryker Corp reported an insider equity award for VP, Chief Communications Officer Kimberly Ann Montagnino. On May 6, 2026, she received 677 Restricted Stock Units (RSUs) of common stock as a compensation grant. These RSUs vest in three equal installments on May 1, 2027, May 1, 2028, and May 1, 2029. Each RSU represents the right to receive one share of Stryker common stock. Following this grant, Montagnino holds 1,872 shares of common stock directly and 33 shares indirectly through a 401(k) plan. The filing shows a routine, non-market grant rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

King Debra reported acquisition or exercise transactions in this Form 4 filing.

Stryker Corp officer Debra King received 1,016 Restricted Stock Units (RSUs) of common stock as equity compensation. The RSUs were granted at no cash cost and increase her direct holdings to 7,569 shares of Stryker common stock, with an additional 8 shares held indirectly through a 401(k) plan.

The 1,016 RSUs vest in three equal installments: one-third on May 1, 2027, one-third on May 1, 2028, and the remaining one-third on May 1, 2029. Each RSU represents a contingent right to receive one share of Stryker common stock as it vests.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Stryker Corporation held its Annual Meeting of Shareholders on May 6, 2026, where shareholders voted on three proposals, including the election of directors. Director nominees generally received strong support, such as Sherilyn S. McCoy with 286,213,500 shares for and 3,785,435 against, and Rajeev Suri with 286,085,744 for and 3,887,285 against, alongside 30,151,420 broker non-votes for each nominee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Stryker Corporation reported solid first quarter 2026 results with some margin pressure and lower adjusted earnings. Net sales rose 2.6% to $6.0 billion, driven by 5.0% growth in MedSurg and Neurotechnology to $3.2 billion, while Orthopaedics was roughly flat at $2.8 billion.

Reported operating income margin improved to 15.5% and reported diluted EPS increased 14.2% to $1.93. However, adjusted operating income margin narrowed to 21.1%, and adjusted diluted EPS declined 8.5% to $2.60 as non-GAAP adjustments fell versus last year.

The company reorganized its Orthopaedics portfolio into a new Ortho Tech business, combining Mako and related technologies with orthopaedic instruments, which recasts prior segment data without changing consolidated results. Stryker maintained its full year 2026 outlook for 8.0%–9.5% organic net sales growth and adjusted EPS of $14.90–$15.10, citing recovery from a recent cyber incident and continued business momentum.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.47%
Tags
current report
-
Rhea-AI Summary

Stryker Corp ownership filing: Vanguard Capital Management reports beneficial ownership of 25,802,180 shares of common stock, representing 6.73% of the class as of 03/31/2026. The filing shows Vanguard has sole dispositive power over 25,802,180 shares and sole voting power for 3,418,999 shares. The statement attributes holdings to Vanguard Capital Management LLC and affiliated business divisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.47%
Tags
ownership
-
Rhea-AI Summary

Ronda E. Stryker filed Amendment No. 8 to update her beneficial ownership in Stryker Corp. She reports beneficial ownership of 15,223,331 common shares, representing 4.0% of the outstanding class. Of these, she has sole voting and dispositive power over 2,235,338 shares and shared power over 12,987,993 shares.

The amendment notes recent activity, including exercising 4,570 options on January 14, 2026, a gift of 655,800 shares initiated on February 2, 2026, a sale of 500,000 shares initiated on February 4, 2026, and a transfer of 42,000 shares on the same date. Stryker indicates she may continue to buy or sell shares over time depending on market conditions and personal considerations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Stryker Corporation filed an Amendment No. 1 to a prior current report to update investors on a March 11, 2026 cybersecurity incident. After further assessment, the company determined the attack had a material impact on its operations and on financial results for the first quarter of 2026.

Stryker reports that its global manufacturing, commercial, ordering and distribution systems are now fully operational, although the investigation remains ongoing. The company currently believes the incident has not had, and is not reasonably likely to have, a material impact on its 2026 full-year guidance, and plans to discuss first-quarter results and its guidance in more detail when it reports earnings on April 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Stryker Corp Schedule 13G/A amendment shows The Vanguard Group reports 0 shares beneficially owned and 0% of the class as of this filing. The filing states an internal realignment effective January 12, 2026 led certain Vanguard subsidiaries to report beneficial ownership separately; Vanguard says it no longer is deemed to beneficially own those subsidiary holdings.

The form is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026. The filing reiterates Vanguard-managed accounts retain rights to dividends and proceeds for reported securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Stryker Corp President and COO Spencer S. Stiles reported routine equity compensation activity. On March 21, 2026, dividend equivalents tied to previously earned performance stock units vested, and 430 Dividend Equivalents were exercised and settled into 430 shares of Common Stock.

To cover related tax obligations, 6,690 shares of Common Stock were disposed of at $335.67 per share through share withholding, not an open-market sale. After these entries, Stiles directly holds 77,634 Common Stock shares and indirectly holds 1,670 shares through a 401(k) plan, indicating a continuing substantial ownership position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Stryker Group President James Andrew Pierce reported routine equity compensation activity tied to previously earned performance stock units. On March 21, 2026, 430 dividend equivalent units were converted into an equal number of Stryker common shares, while 7,807 shares were delivered to cover tax obligations. Following these transactions, Pierce holds 80,869 Stryker common shares directly, plus indirect holdings of 712 shares through Son GP, 713 shares through Son AP, and 1,595 shares through a 401(k) account.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Stryker (SYK) SEC filings are available on StockTitan?

StockTitan tracks 94 SEC filings for Stryker (SYK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Stryker (SYK)?

The most recent SEC filing for Stryker (SYK) was filed on May 8, 2026.